Credit Suisse’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $465K | Buy |
144,726
+6,146
| +4% | +$19.7K | ﹤0.01% | 2663 |
|
|
2023
Q4 | $679K | Buy |
138,580
+11,019
| +9% | +$54K | ﹤0.01% | 2569 |
|
|
2023
Q3 | $695K | Sell |
127,561
-5,173
| -4% | -$28.2K | ﹤0.01% | 2492 |
|
|
2023
Q2 | $891K | Buy |
132,734
+10,133
| +8% | +$68K | ﹤0.01% | 2444 |
|
|
2023
Q1 | $1.08M | Buy |
122,601
+3,910
| +3% | +$34.5K | ﹤0.01% | 2259 |
|
|
2022
Q4 | $907K | Buy |
118,691
+20,304
| +21% | +$155K | ﹤0.01% | 2390 |
|
|
2022
Q3 | $700K | Buy |
98,387
+7,874
| +9% | +$56K | ﹤0.01% | 2559 |
|
|
2022
Q2 | $732K | Buy |
90,513
+2,720
| +3% | +$22K | ﹤0.01% | 2577 |
|
|
2022
Q1 | $1.22M | Buy |
87,793
+10,226
| +13% | +$142K | ﹤0.01% | 2401 |
|
|
2021
Q4 | $2.18M | Sell |
77,567
-9,519
| -11% | -$267K | ﹤0.01% | 2098 |
|
|
2021
Q3 | $2.96M | Buy |
87,086
+2,656
| +3% | +$90.3K | ﹤0.01% | 1892 |
|
|
2021
Q2 | $3.45M | Buy |
84,430
+4,767
| +6% | +$195K | ﹤0.01% | 1800 |
|
|
2021
Q1 | $3.21M | Buy |
79,663
+9,675
| +14% | +$389K | ﹤0.01% | 1852 |
|
|
2020
Q4 | $4.14M | Buy |
69,988
+2,995
| +4% | +$177K | ﹤0.01% | 1654 |
|
|
2020
Q3 | $3.26M | Sell |
66,993
-77,534
| -54% | -$3.77M | ﹤0.01% | 1518 |
|
|
2020
Q2 | $6.99M | Buy |
144,527
+136,523
| +1,706% | +$6.6M | 0.01% | 1142 |
|
|
2020
Q1 | $222K | Buy |
+8,004
| New | +$222K | ﹤0.01% | 2988 |
|
|
2019
Q3 | – | Sell |
-61,000
| Closed | -$2.95M | – | 3422 |
|
|
2019
Q2 | $2.95M | Buy |
+61,000
| New | +$2.95M | ﹤0.01% | 1687 |
|